Skip to main content
Premium Trial:

Request an Annual Quote

Tepnel Adds Illumina's iScan System to Services Offering

NEW YORK (GenomeWeb News) – Tepnel Life Sciences has added Illumina’s iScan System to the collection of instruments it uses to perform genetic analysis services for customers.
 
Manchester, UK-based Tepnel said that the addition of the iScan makes the firm the first commercial provider of iScan services within the UK. It said that it now offers a full suite of complementary services from DNA extraction through to bioinformatics.
 
According to Tepnel, the iScan is capable of generating up to 225 million genotypes per day. That is in addition to the other platforms and techniques for SNP-based investigations that Tepnel uses for human and non-human research and clinical applications.
 
"This new addition to our service opens up the possibility to our customers of whole genome association, focused content analysis, copy number variation analysis and, epigenetics on both human and non-human samples, all within a regulatory compliant environment,” said David Scott, general manager of Tepnel’s Livingston facility, in a statement.
 
Illumina launched the iScan system, which can complete genotyping studies up to six times faster than studies run on its BeadStation, earlier this year.
 

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.